Patents by Inventor Dominik Megger

Dominik Megger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for cholangiocellular carcinoma (CCC)
    Patent number: 10429391
    Abstract: The invention relates to a method for identifying specific marker proteins (biomarkers) for cholangiocellular carcinoma (CCC), the biomarkers for CCC identified by the method and the use thereof, in particular for diagnosis, surveillance and treatment. The invention further relates to a diagnostic device comprising the biomarkers for CCC and a screening assay wherein these biomarkers for CCC are used to identify novel pharmaceutical compounds for treatment of CCC.
    Type: Grant
    Filed: September 8, 2014
    Date of Patent: October 1, 2019
    Assignee: LEIBNIZ-INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN—ISAS—E.V.
    Inventors: Barbara Sitek, Helmut E. Meyer, Dominik Megger, Thilo Bracht, Juliet Padden, Hideo A. Baba, Jörg F. Schlaak, Frank Weber
  • BIOMARKERS FOR CHOLANGIOCELLULAR CARCINOMA (CCC)
    Publication number: 20160195537
    Abstract: The invention relates to a method for identifying specific marker proteins (biomarkers) for cholangiocellular carcinoma (CCC), the biomarkers for CCC identified by the method and the use thereof, in particular for diagnosis, surveillance and treatment. The invention further relates to a diagnostic device comprising the biomarkers for CCC and a screening assay wherein these biomarkers for CCC are used to identify novel pharmaceutical compounds for treatment of CCC.
    Type: Application
    Filed: September 8, 2014
    Publication date: July 7, 2016
    Inventors: Barbara SITEK, Helmut E. MEYER, Dominik A. MEGGER, Thilo BRACHT, Juliet PADDEN, Hideo A. BABA, Jörg F. SCHLAAK, Frank WEBER
  • SPECIFIC BIOMARKERS FOR HEPATOCELLULAR CARCINOMA (HCC)
    Publication number: 20150147761
    Abstract: The invention relates to specific marker proteins (biomarkers) for Hepatocellular carcinoma (HCC). The invention relates to a method for the diagnostic study of biological samples of a human for Hepatocellular carcinoma, the sample being studied for one or more proteins as a marker for Hepatocellular carcinoma, a concentration of the proteins which is elevated or decreased in relation to the healthy state indicating the presence of Hepatocellular carcinoma, a diagnostic test kit and a method of screening compounds effective in HCC.
    Type: Application
    Filed: June 20, 2013
    Publication date: May 28, 2015
    Inventors: Helmut E. Meyer, Barbara Sitek, Dominik A. Megger, Thilo Bracht, Hideo Andreas Baba, Joerg Friedrich Schlaak, Frank Weber